N-(2-Thiazolyl)-amide derivatives as GSK-3 inhibitors
申请人:Neuropharma, S.A.
公开号:EP1849785A1
公开(公告)日:2007-10-31
The present invention relates to the use of N-(2-thiazolyl)-amide derivatives of formula (I)
wherein
X is selected from the group consisting of:
- an indol of formula (A) or (B), bonded respectively at positions 2 or 3:
- an indazol of formula (C), bonded at position 3:
- a pyridin, bonded at any positions 2 to 6; and
- a phenyl
for the treatment and/or prophylaxis of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, especially neurodegenerative diseases, such as Alzheimer's disease, or non-insulin dependent diabetes mellitus.
N-(2-THIAZOLYL)-AMIDE DERIVATIVES AS GSK-3 INHIBITORS
申请人:Martinez Gil Ana
公开号:US20090221647A1
公开(公告)日:2009-09-03
The present invention relates to the use of N-(2-thiazolyl)-amide derivatives of formula (I), for the treatment and/or prophylaxis of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, especially neurodegenerative diseases, such as Alzheimer's disease, or non-insulin dependent diabetes mellitus.
Pyridine-mediated efficient synthesis of (benzo)thiazoles-containing amides via the acylation of 2‐amino(benzo)thiazoles under ultrasonic irradiation
作者:Zengyang Xie、Chuan-Ang Yu、Luying Xie、Jingjie Tang、Jiayu Liu、Shangyu Shi
DOI:10.1016/j.molstruc.2024.138200
日期:2024.8
An efficient and practical methodology for the synthesis of (benzo)thiazoles-containing amides through pyridine-mediated acylation of 2‐amino(benzo)thiazoles under ultrasonic irradiation was developed. The short reaction time (within 1 min), good functional group tolerance, experimental simplicity and ease of scale-up were salient features of the present strategy, which enables straightforward access